STOCK TITAN

Adaptive Biotechnologies to Report Third Quarter Financial Results on November 9, 2023

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary
Adaptive Biotechnologies Corporation will report financial results for Q3 2023 on November 9, 2023. The company aims to translate the genetics of the adaptive immune system into clinical products. The conference call will be webcasted and available for replay on the company website.
Positive
  • None.
Negative
  • None.

SEATTLE, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will report financial results for the third quarter of 2023 after market close on Thursday, November 9, 2023. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Live audio of the webcast will be available on the “Investors” section of the company website at: www.adaptivebiotech.com. The webcast will be archived and available for replay within 24 hours after the event.

About Adaptive Biotechnologies

Adaptive Biotechnologies is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. We believe the adaptive immune system is nature’s most finely tuned diagnostic and therapeutic for most diseases, but the inability to decode it has prevented the medical community from fully leveraging its capabilities. Our proprietary immune medicine platform reveals and translates the massive genetics of the adaptive immune system with scale, precision and speed to develop products in our Immune Medicine and Minimal Residual Disease (MRD) businesses. For more information, please visit adaptivebiotech.com and follow us on www.twitter.com/adaptivebiotech.

ADAPTIVE INVESTORS
Karina Calzadilla, Vice President, Investor Relations
201-396-1687
investors@adaptivebiotech.com

ADAPTIVE MEDIA
Erica Jones, Associate Corporate Communications
206-279-2423
media@adaptivebiotech.com



FAQ

When will Adaptive Biotechnologies report its Q3 2023 financial results?

Adaptive Biotechnologies will report its Q3 2023 financial results on November 9, 2023.

What does Adaptive Biotechnologies do?

Adaptive Biotechnologies is a biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products.

Where can I listen to the conference call?

The conference call will be webcasted and can be accessed on the 'Investors' section of the company website at www.adaptivebiotech.com.

Will the webcast of the conference call be available for replay?

Yes, the webcast will be archived and available for replay within 24 hours after the event.

Adaptive Biotechnologies Corporation

NASDAQ:ADPT

ADPT Rankings

ADPT Latest News

ADPT Stock Data

589.47M
147.37M
2.02%
100.66%
8.85%
Biological Product (except Diagnostic) Manufacturing
Manufacturing
Link
United States of America
SEATTLE